Merck
CN
  • A practical guide for diagnosis and treatment of arteriovenous malformations in the oral and maxillofacial region.

A practical guide for diagnosis and treatment of arteriovenous malformations in the oral and maxillofacial region.

The Chinese journal of dental research : the official journal of the Scientific Section of the Chinese Stomatological Association (CSA) (2014-12-23)
Li Xin Su, Xin Dong Fan, Jia Wei Zheng, Yan An Wang, Zhong Ping Qin, Xu Kai Wang, Yao Wu Yang, Yi Fang Zhao
摘要

Arteriovenous malformations (AVMs) are congenital vascular malformations (CVMs) resulting from birth defects of the vasculature. It is rarely seen, only accounting for 1.5% of all vascular anomalies, and 50% of the lesions are located in the oral and maxillofacial region. Regardless of the type, AVMs may ultimately lead to significant anatomical, pathophysiological and hemodynamic consequences. Therefore, despite their relative rarity, AVMs still remain the most challenging and/or life-threatening form of vascular anomalies. Transarterial coil embolisation or ligation of feeding arteries are incorrect approaches and may result in progress of the lesion. Furthermore, such procedures would prevent future endovascular access to the lesions via the arterial route, and should be abandoned. Interventional embolisation using various sclerosants is currently the mainstay of treatment for AVMs, and elimination of the nidus (if present) is the key to success. Among various embolosclerotherapy agents, ethanol sclerotherapy produces the best long-term outcomes, with minimal complications. For more complex cases, multidisciplinary approaches and interventions may provide an excellent potential for a curative result. Based on the published literature and clinical experiences, a practical treatment guideline was established in order to provide a criterion for the management of oral and maxillofacial AVMs. This protocol will be renewed and updated to reflect cutting edge knowledge, and provide the newest treatment modalities for oral and maxillofacial AVMs.

材料
货号
品牌
产品描述

Sigma-Aldrich
纯乙醇, 200 proof, for molecular biology
Sigma-Aldrich
纯乙醇, 200 proof, anhydrous, ≥99.5%
Sigma-Aldrich
纯乙醇, 200 proof, ACS reagent, ≥99.5%
Sigma-Aldrich
纯乙醇, 200 proof, HPLC/spectrophotometric grade
Sigma-Aldrich
酒精, BioUltra, for molecular biology, ≥99.8%, (absolute alcohol, without additive, A15 o1)
Sigma-Aldrich
聚乙烯醇, Mw 89,000-98,000, 99+% hydrolyzed
Sigma-Aldrich
聚乙烯醇, 87-90% hydrolyzed, average mol wt 30,000-70,000
Sigma-Aldrich
纯乙醇, 200 proof, meets USP testing specifications
Sigma-Aldrich
纯乙醇, 190 proof, ACS spectrophotometric grade, 95.0%
Sigma-Aldrich
乙醇,变性, reagent grade
Supelco
酒精, standard for GC
Sigma-Aldrich
纯乙醇, 190 proof, for molecular biology
Sigma-Aldrich
酒精试剂, reagent grade
Supelco
无水乙醇, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
聚乙烯醇, Mw 9,000-10,000, 80% hydrolyzed
Sigma-Aldrich
聚乙烯醇, Mw 13,000-23,000, 87-89% hydrolyzed
Sigma-Aldrich
聚乙烯醇, Mw 146,000-186,000, 99+% hydrolyzed
Sigma-Aldrich
® 4-88, Mw ~31,000
Sigma-Aldrich
酒精试剂, suitable for HPLC
Sigma-Aldrich
纯乙醇, 190 proof, meets USP testing specifications
Sigma-Aldrich
聚乙烯醇, Mw 31,000-50,000, 98-99% hydrolyzed
Sigma-Aldrich
酒精试剂, anhydrous, ≤0.003% water
Sigma-Aldrich
聚乙烯醇, Mw 85,000-124,000, 99+% hydrolyzed
Sigma-Aldrich
酒精试剂, anhydrous, ≤0.005% water
Sigma-Aldrich
聚乙烯醇, Fully hydrolyzed
Supelco
Ethanol 溶液, certified reference material, 2000 μg/mL in methanol
Sigma-Aldrich
酒精, puriss. p.a., absolute, ≥99.8% (GC)
Sigma-Aldrich
聚乙烯醇, average Mw 85,000-124,000, 87-89% hydrolyzed
Sigma-Aldrich
聚乙烯醇, average Mw 13,000-23,000, 98% hydrolyzed
Sigma-Aldrich
Mowiol® 18-88 聚(乙烯醇), Mw ~130,000